226 related articles for article (PubMed ID: 26867567)
21. CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.
Zhang S; Yang YL; Wang Y; You B; Dai Y; Chan G; Hsieh D; Kim IJ; Fang LT; Au A; Stoppler HJ; Xu Z; Jablons DM; You L
J Exp Clin Cancer Res; 2014 Nov; 33(1):93. PubMed ID: 25422081
[TBL] [Abstract][Full Text] [Related]
22. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
23. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
Plowright L; Harrington KJ; Pandha HS; Morgan R
Br J Cancer; 2009 Feb; 100(3):470-5. PubMed ID: 19156136
[TBL] [Abstract][Full Text] [Related]
24. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.
Krosl J; Baban S; Krosl G; Rozenfeld S; Largman C; Sauvageau G
Oncogene; 1998 Jul; 16(26):3403-12. PubMed ID: 9692548
[TBL] [Abstract][Full Text] [Related]
25. Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway.
Kim KH; Yoon G; Cho JJ; Cho JH; Cho YS; Chae JI; Shim JH
Int J Oncol; 2015 Mar; 46(3):1385-92. PubMed ID: 25586190
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract][Full Text] [Related]
27. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif.
Phelan ML; Rambaldi I; Featherstone MS
Mol Cell Biol; 1995 Aug; 15(8):3989-97. PubMed ID: 7623795
[TBL] [Abstract][Full Text] [Related]
28. Engrailed and Hox homeodomain proteins contain a related Pbx interaction motif that recognizes a common structure present in Pbx.
Peltenburg LT; Murre C
EMBO J; 1996 Jul; 15(13):3385-93. PubMed ID: 8698039
[TBL] [Abstract][Full Text] [Related]
29. Residues flanking the HOX YPWM motif contribute to cooperative interactions with PBX.
Shanmugam K; Featherstone MS; Saragovi HU
J Biol Chem; 1997 Jul; 272(30):19081-7. PubMed ID: 9228093
[TBL] [Abstract][Full Text] [Related]
30. Conformational changes in the PBX homeodomain and C-terminal extension upon binding DNA and HOX-derived YPWM peptides.
Sprules T; Green N; Featherstone M; Gehring K
Biochemistry; 2000 Aug; 39(32):9943-50. PubMed ID: 10933814
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
32. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
33. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
[TBL] [Abstract][Full Text] [Related]
34. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
[TBL] [Abstract][Full Text] [Related]
35. Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.
Blum W; Pecze L; Rodriguez JW; Steinauer M; Schwaller B
BMC Cancer; 2018 Apr; 18(1):475. PubMed ID: 29699512
[TBL] [Abstract][Full Text] [Related]
36. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
37. MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Maille E; Brosseau S; Hanoux V; Creveuil C; Danel C; Bergot E; Scherpereel A; Mazières J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Langlais A; Morin F; Levallet G; Zalcman G
Br J Cancer; 2019 Feb; 120(4):387-397. PubMed ID: 30739911
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
Alharbi RA; Pandha HS; Simpson GR; Pettengell R; Poterlowicz K; Thompson A; Harrington K; El-Tanani M; Morgan R
Oncotarget; 2017 Oct; 8(52):89566-89579. PubMed ID: 29163771
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.
Borchert S; Wessolly M; Schmeller J; Mairinger E; Kollmeier J; Hager T; Mairinger T; Herold T; Christoph DC; Walter RFH; Eberhardt WEE; Plönes T; Wohlschlaeger J; Aigner C; Schmid KW; Mairinger FD
BMC Cancer; 2019 Jan; 19(1):108. PubMed ID: 30700254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]